| 1 |
27509880 | Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells. | 2016 Oct |
1 |
| 2 |
22112863 | The HDAC inhibitor depsipeptide transactivates the p53/p21 pathway by inducing DNA damage. | 2012 Feb 1 |
1 |
| 3 |
19233470 | Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines. | 2009 Jul |
1 |
| 4 |
17644301 | Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. | 2008 Feb |
1 |
| 5 |
14996704 | T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance. | 2004 Jun 15 |
1 |
| 6 |
12773551 | Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. | 2003 Jun |
1 |
| 7 |
12481415 | Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity. | 2002 Sep |
1 |